Patent Assignment
Reel/Frame 043029/0338
Change of Name
Recorded: 2017-06-28
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Chimeric Oligomeric Compounds for Modulation of Splicing
Modulation of HIF1(Alpha) and HIF2(Alpha) Expression
Antisense Modulation of Kinesin-Like 1 Expression
Modulation of Apolipoprotein C-Iii Expression
Bicyclic Cyclohexitol Nucleic Acid Analogs
Modulation of Smrt Expression
Methods for Modulating Expression of RBP4
Substituted Alpha-L-Bicyclic Nucleosides
Tetrahydropyran Nucleic Acid Analogs
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest
Aug 15, 2013
From: JAIN, RAVI
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 031020/0761 →
Assignment of Assignor's Interest
Feb 13, 2014
From: BENNETT, C. FRANK; DEAN, NICHOLAS M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 032212/0100 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →